TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 46 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,390,807 | -37.6% | 6,041,910 | +8.6% | 1.64% | -36.9% |
| Q2 2023 | $48,666,056 | +19.2% | 5,561,835 | +61.3% | 2.60% | +50.8% |
| Q1 2023 | $40,827,576 | +16.3% | 3,448,275 | 0.0% | 1.72% | +17.0% |
| Q4 2022 | $35,103,440 | +1042.7% | 3,448,275 | +178.4% | 1.47% | +1159.8% |
| Q2 2022 | $3,072,000 | -16.5% | 1,238,800 | 0.0% | 0.12% | +4.5% |
| Q1 2022 | $3,679,000 | -58.0% | 1,238,800 | 0.0% | 0.11% | -34.1% |
| Q4 2021 | $8,758,000 | -25.3% | 1,238,800 | +10.0% | 0.17% | -14.1% |
| Q3 2021 | $11,730,000 | -15.0% | 1,125,736 | +0.1% | 0.20% | -3.9% |
| Q2 2021 | $13,794,000 | -44.3% | 1,125,136 | 0.0% | 0.21% | -43.7% |
| Q1 2021 | $24,753,000 | – | 1,125,136 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |